Diabetes and Other Diseases
655 articles
Pancreatic Cancer Pain Management a Zap Away
Dr. Yaacov Lawrence discusses the results of his clinical trial using SBRT radiotherapy for pain management of pancreatic tumors.
An Exemplary Life: The PR Lessons Anne Glauber Left Us
A tribute to the life, works, and pancreatic cancer treatment education mission of Anne Glauber, founder of Let’s Win, by Seth Arenstein.
In Safe Hands: Selecting the Right Whipple Surgeon
The Whipple procedure is a complex surgery–how do you find an expert with the vast experience needed for your surgery?
Meet the World Pancreatic Cancer Coalition
The World Pancreatic Cancer Coalition shows there is power when advocacy groups join together for the cause: World Pancreatic Cancer Day.
Patient-Focused Research to Better Understand Pancreatic Cancer
Dr. Diane Simeone stresses the importance of research and clinical trials to get better results for pancreatic cancer patients.
CAR T Cell Trial Targets Mesothelin
In an immunotherapy clinical trial, Dr. Mark O’Hara is using CAR T cells to attack mesothelin-expressing tumor cells in pancreatic cancer.
Pancreatic Cancer Organizations Join in Mourning Aretha Franklin
Let’s Win and the Elvin Howard, Sr. Pancreatic Cancer Advocacy Foundation join in mourning Aretha Franklin, and to raise awareness of pancreatic cancer.
Let’s Win Receives Biden Cancer Initiative FIERCE Award
Let’s Win! Pancreatic Cancer Foundation is the inaugural winner of the Biden Cancer Initiative FIERCE Award for “Leadership through Exemplary and Awesome Purpose (LEAP).”
Let’s Learn About Pancreatic Cancer
Let’s Win and the National Alliance for Hispanic Health’s Nuestras Voces program held their first webinar in Spanish.
Tumor Staging and Pancreatic Cancer
What is tumor staging and how does it affect treatment? Dr. Shubham Pant helps explain how pancreatic cancer tumors are staged and graded.
Collaborative Multi-Center Immunotherapy Trial Targets CD40 and PD-1
Dr. Mark O’Hara outlines a collaborative clinical trial of two immunotherapy agents–a checkpoint inhibitor and a monoclonal antibody–plus standard chemotherapy.